- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
TORONTO, ONTARIO–(Marketwired – Nov. 2, 2016) – Mettrum Health Corp. (TSXV:MT.V), a vertically integrated provider of cannabis products, is pleased to announce the renewals of its sales and production licenses at its two Bowmanville facilities. Following these license renewals, Mettrum’s Company-wide total licensed sales and production capacity stands at 5,600 kilograms per annum.
TORONTO, ONTARIO–(Marketwired – Nov. 2, 2016) – Mettrum Health Corp. (TSXV:MT.V), a vertically integrated provider of cannabis products, is pleased to announce the renewals of its sales and production licenses at its two Bowmanville facilities. Following these license renewals, Mettrum’s Company-wide total licensed sales and production capacity stands at 5,600 kilograms per annum.
The Company is also pleased to announce that the phase 2 expansion at its 60,000 square foot state-of-the-art production facility in Bowmanville (“Bowmanville South”) is on track and will double its production capacity to approximately12,000 kg before the end of the fiscal year ending March 31, 2017.
“Our ample capacity to service the needs of our growing client base combined with the expansion of our Bowmanville South facility leaves us very well positioned for growth within this exciting accelerating medical cannabis market and prepared for the recreational cannabis market in the future,” said Michael Haines, Chief Executive Officer of Mettrum.
Read the full press release.
Connect with Mettrum Health Corp. (TSXV:MT.V) to receive an Investor Presentation.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.